AbbVie to Host Third-Quarter 2026 Earnings Conference Call
Get Alerts ABBV Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.6%
EPS Growth %: +107.5%
Join SI Premium – FREE
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.
|
Media:
|
Investors:
|
View original content:https://www.prnewswire.com/news-releases/abbvie-to-host-third-quarter-2026-earnings-conference-call-302895088.html
SOURCE AbbVie
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- Civil Rights and Trial Attorney John Gomez Announces Wrongful Death Lawsuit After Developmentally Disabled Man Killed at Fallbrook Care Facility
- RBC cuts Northrop Grumman rating on slower growth, cautious defense outlook
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share